Parer-Richard C - Search Results

1

Effect of Miglitol (Bay m1099), a new alpha-glucosidase inhibitor, on glucose, insulin, C-peptide and GIP responses to an oral sucrose load in patients with post-prandial hypoglycaemic symptoms.

Renard E, Parer-Richard C, Richard JL, Jureidini S, Orsetti A, Mirouze J. Renard E, et al. Among authors: parer richard c. Diabete Metab. 1991 May-Jun;17(3):355-62. Diabete Metab. 1991. PMID: 1884880 Clinical Trial.

2

[Methods of analysis of hormonal pulsatility].

Richard JL, Bringer J, Daurès JP, Parer-Richard C, Jaffiol C, Mirouze J. Richard JL, et al. Among authors: parer richard c. Ann Endocrinol (Paris). 1990;51(5-6):181-93. Ann Endocrinol (Paris). 1990. PMID: 2130758 Review. French.

3

[Provisional intensive insulin therapy in non-insulin-dependent diabetes resistant to usual treatment].

Bringer J, Galtier-Dereure F, Augustin-Pascalis I, Richard JL, Parer-Richard C, Mirouze J, Jaffiol C. Bringer J, et al. Among authors: parer richard c. Journ Annu Diabetol Hotel Dieu. 1993:115-22. Journ Annu Diabetol Hotel Dieu. 1993. PMID: 8331859 Review. French. No abstract available.

4

Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study.

Richard JL, Parer-Richard C, Daures JP, Clouet S, Vannereau D, Bringer J, Rodier M, Jacob C, Comte-Bardonnet M. Richard JL, et al. Among authors: parer richard c. Diabetes Care. 1995 Jan;18(1):64-9. doi: 10.2337/diacare.18.1.64. Diabetes Care. 1995. PMID: 7698050 Clinical Trial.

5

Impact of the new ADA diagnostic criteria for diabetes on an obese population: comparison with OGTT-based who criteria. Preliminary results.

Richard JL, Vannereau D, Parer-Richard C. Richard JL, et al. Among authors: parer richard c. Diabetes Metab. 1998 Sep;24(4):365-7. Diabetes Metab. 1998. PMID: 9805649 No abstract available.

6

Diagnosis of diabetes mellitus and intermediate glucose abnormalities in obese patients based on ADA (1997) and WHO (1985) criteria.

Richard JL, Sultan A, Daures JP, Vannereau D, Parer-Richard C. Richard JL, et al. Among authors: parer richard c. Diabet Med. 2002 Apr;19(4):292-9. doi: 10.1046/j.1464-5491.2002.00647.x. Diabet Med. 2002. PMID: 11943000

7

Renal changes associated with cyclosporine in recent type I diabetes mellitus.

Rodier M, Ribstein J, Parer-Richard C, Mimran A. Rodier M, et al. Among authors: parer richard c. Hypertension. 1991 Sep;18(3):334-40. doi: 10.1161/01.hyp.18.3.334. Hypertension. 1991. PMID: 1889846

8

[Which treatment can be proposed to a diabetic patient presenting with secondary failure of oral antidiabetics?].

Blanc MH, Galtier-Dereure F, Parer-Richard C, Bringer J, Jaffiol C. Blanc MH, et al. Among authors: parer richard c. Rev Med Suisse Romande. 1993 Nov;113(11):955-61. Rev Med Suisse Romande. 1993. PMID: 8272722 Review. French. No abstract available.

9

Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study.

Leiter LA, Lundman P, da Silva PM, Drexel H, Jünger C, Gitt AK; DYSIS investigators. Leiter LA, et al. Diabet Med. 2011 Nov;28(11):1343-51. doi: 10.1111/j.1464-5491.2011.03360.x. Diabet Med. 2011. PMID: 21679231

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters